INTRACEREBRAL INJECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 COAT PROTEIN GP120 DIFFERENTIALLY AFFECTS THE EXPRESSION OF NERVE GROWTH-FACTOR AND NITRIC-OXIDE SYNTHASE IN THE HIPPOCAMPUS OF RAT
G. Bagetta et al., INTRACEREBRAL INJECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 COAT PROTEIN GP120 DIFFERENTIALLY AFFECTS THE EXPRESSION OF NERVE GROWTH-FACTOR AND NITRIC-OXIDE SYNTHASE IN THE HIPPOCAMPUS OF RAT, Proceedings of the National Academy of Sciences of the United Statesof America, 93(2), 1996, pp. 928-933
We have studied the neuropathological characteristics of the brain of
rats receiving daily intracerebroventricular administration of freshly
dissolved human immunodeficiency virus type 1 recombinant protein gp1
20 (100 ng per rat per day) given for up to 14 days. Histological exam
ination of serial brain sections revealed no apparent gross damage to
the cortex or hippocampus, nor did cell counting yield significant neu
ronal cell loss. However, the viral protein caused after 7 and 14 days
of treatment DNA fragmentation in 10% of brain cortical neurons, Inte
restingly, reduced neuronal nitric oxide synthase (NOS) expression alo
ng with significant increases in nerve growth factor (NGF) were observ
ed in the hippocampus, where gp120 did not cause neuronal damage. No c
hanges in NGF and NOS expression were seen in the cortex, where cell d
eath is likely to be of the apoptotic type. The present data demonstra
te that gp120-induced cortical cell death is associated with the lack
of increase of NGF in the cerebral cortex and suggest that the latter
may be important for the expression of neuropathology in the rat brain
. By contrast, enhanced levels of NGF may prevent or delay neuronal de
ath in the hippocampus, where reduced NOS expression may be a reflecti
on of a subcellular insult inflicted by the viral protein.